Ligand-based drug discovery against RNA using mass spectrometry.

被引：0

作者：

Swayze, EE ^{[1
]}

Hofstadler, SA ^{[1
]}

Lowery, K ^{[1
]}

Drader, J ^{[1
]}

Jefferson, EA ^{[1
]}

Osgood, S ^{[1
]}

Ding, YL ^{[1
]}

Sprankle, KG ^{[1
]}

Griffey, RH ^{[1
]}

机构：

[1] ISIS Pharmaceut, Ibis Therapeut Div, Carlsbad, CA 92008 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 221卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

216-MEDI

引用

页码：U38 / U38

页数：1

共 50 条

[21] Ligand-based lead discovery and applications to "scaffold hopping".
Lanza, G
Yu, J
Mydlowec, W
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U478 - U478
[22] Flavoprotein cofactor identification using mass spectrometry.
Barber, MJ
[J]. FASEB JOURNAL, 1999, 13 (07): : A1437 - A1437
[23] Chemical genetics: Ligand-based discovery of gene function
Stockwell, BR
[J]. NATURE REVIEWS GENETICS, 2000, 1 (02) : 116 - 125
[24] Re-Imagining Drug Discovery using Mass Spectrometry
Cooks, R. Graham
Feng, Yunfei
Huang, Kai-Hung
Morato, Nicolas M.
Qiu, Lingqi
[J]. ISRAEL JOURNAL OF CHEMISTRY, 2023, 63 (7-8)
[25] Drug profiling and biomarker discovery using mass spectrometry-based proteomics technologies
Jenne, A.
Tebbe, A.
Schaab, C.
Godl, K.
Kaminski, M.
Mueller, S.
[J]. JOURNAL OF BIOTECHNOLOGY, 2010, 150 : S29 - S29
[26] Using mass spectrometry to determine ADME properties in drug discovery
Unger, SE
[J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34, 1999, 34 : 307 - 316
[27] Affinity-based methods for mass spectrometry.
Clarke, W
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U144 - U144
[28] Data management for ligand-based drug design
Aberer, K
Hemm, K
Hendlich, M
[J]. THEORETICAL AND COMPUTATIONAL METHODS IN GENOME RESEARCH, 1997, : 205 - 230
[29] Network analysis and ligand-based pharmacophore modeling for discovery of small molecule against glioblastoma multiforme
Radhakrishnan, Vishnu Vasanthi
Benny, Sonu
Presanna, Aneesh Thankappan
[J]. FUTURE MEDICINAL CHEMISTRY, 2022, 14 (16) : 1203 - 1218
[30] Ligand-based receptor tyrosine kinase partial agonists: new paradigm for cancer drug discovery?
Riese, David J., II
[J]. EXPERT OPINION ON DRUG DISCOVERY, 2011, 6 (02) : 185 - 193

← 1 2 3 4 5 →